Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2010 1
2012 1
2014 1
2015 1
2017 3
2018 2
2019 4
2020 6
2021 5
2022 3
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Next-Generation Approaches to Immuno-Oncology in GI Cancers.
Hecht JR, Mitchell J, Morelli MP, Anandappa G, Yang JC. Hecht JR, et al. Am Soc Clin Oncol Educ Book. 2023 Jun;43:e389072. doi: 10.1200/EDBK_389072. Am Soc Clin Oncol Educ Book. 2023. PMID: 37290032 Free article. Review.
Rationale, discovery and clinical development of NEO-201.
Arlen PM, Morelli MP. Arlen PM, et al. Expert Opin Biol Ther. 2020 Feb;20(2):105-108. doi: 10.1080/14712598.2020.1696767. Epub 2019 Dec 24. Expert Opin Biol Ther. 2020. PMID: 31755317 No abstract available.
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors.
Cole CB, Morelli MP, Fantini M, Miettinen M, Fetsch P, Peer C, Figg WD, Yin T, Houston N, McCoy A, Lipkowitz S, Zimmer A, Lee JM, Pavelova M, Villanueva EN, Trewhitt K, Solarz BB, Fergusson M, Mavroukakis SA, Zaki A, Tsang KY, Arlen PM, Annunziata CM. Cole CB, et al. J Exp Clin Cancer Res. 2023 Mar 29;42(1):76. doi: 10.1186/s13046-023-02649-6. J Exp Clin Cancer Res. 2023. PMID: 36991390 Free PMC article. Clinical Trial.
Survival improvement for patients with metastatic colorectal cancer over twenty years.
Zeineddine FA, Zeineddine MA, Yousef A, Gu Y, Chowdhury S, Dasari A, Huey RW, Johnson B, Kee B, Lee MS, Morelli MP, Morris VK, Overman MJ, Parseghian C, Raghav K, Willis J, Wolff RA, Kawaguchi Y, Vauthey JN, Sun R, Kopetz S, Shen JP. Zeineddine FA, et al. NPJ Precis Oncol. 2023 Feb 13;7(1):16. doi: 10.1038/s41698-023-00353-4. NPJ Precis Oncol. 2023. PMID: 36781990 Free PMC article.
Hurdles and complexities of codon 13 KRAS mutations.
Morelli MP, Kopetz S. Morelli MP, et al. J Clin Oncol. 2012 Oct 10;30(29):3565-7. doi: 10.1200/JCO.2012.43.6535. Epub 2012 Aug 27. J Clin Oncol. 2012. PMID: 22927534 No abstract available.
Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.
Simmons K, Thomas JV, Ludford K, Willis JA, Higbie VS, Raghav KPS, Johnson B, Dasari A, Kee BK, Parseghian CM, Lee MS, Le PH, Morelli MP, Shen JP, Bent A, Vilar E, Wolff RA, Kopetz S, Overman MJ, Morris VK. Simmons K, et al. Among authors: morelli mp. Cancer Res Commun. 2023 Dec 11;3(12):2510-2517. doi: 10.1158/2767-9764.CRC-23-0340. Cancer Res Commun. 2023. PMID: 38085001 Free PMC article.
PGE2 displays immunosuppressive effects during human active tuberculosis.
Pellegrini JM, Martin C, Morelli MP, Schander JA, Tateosian NL, Amiano NO, Rolandelli A, Palmero DJ, Levi A, Ciallella L, Colombo MI, García VE. Pellegrini JM, et al. Sci Rep. 2021 Jun 30;11(1):13559. doi: 10.1038/s41598-021-92667-1. Sci Rep. 2021. PMID: 34193890 Free PMC article. Clinical Trial.
34 results